FLGT 8-K: SEC filing
Fulgent Genetics
Filed with the SEC on · accession 0001193125-26-449799
FLGT filed a 8-K (current report) with the SEC on Nov 5, 2026. Fulgent Genetics issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026, and updated its investor presentation.
Summary of the filing
Fulgent Genetics issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026, and updated its investor presentation. The filing is a routine earnings-related 8-K furnished under Items 2.02 and 7.01.
Key details
✦ Ask GOAX AI about this filing — what it means for FLGT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FLGT?
Click hereFrequently asked questions
What did FLGT file with the SEC on Nov 5, 2026?
FLGT filed a 8-K (SEC filing). Fulgent Genetics issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026, and updated its investor presentation. The filing is a routine earnings-related 8-K furnished under Items 2.02 and 7.01.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other FLGT SEC filings
Get alerts when FLGT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days